Johnson & Johnson News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

17.12.21	CDC Recommends Pfizer, Moderna COVID-19 Vaccines Over J&J Due To Rare Blood Clots (RTTNews)
15.12.21	Johnson & Johnson Receives Positive CHMP Opinion For Booster Shot Of COVID-19 Vaccine (RTTNews)
15.12.21	Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine (PR Newswire)
15.12.21	EMA Recommends Covid-19 Vaccine Janssen Booster Shot For Adults (RTTNews)
13.12.21	J&J Talcum Powder Woes Continue As SC Declines To Hear The Company (RTTNews)
10.12.21	Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results (PR Newswire)
09.12.21	World Health Organization Strategic Advisory Group of Experts (SAGE) Interim Recommendation Supports Use of Johnson & Johnson COVID-19 Vaccine as a Booster (PR Newswire)
09.12.21	Johnson & Johnson Appoints Senior Leaders to Executive Committee (PR Newswire)
06.12.21	Johnson & Johnson Says Its COVID-19 Booster Shows Increase In Antibody And T-cell Responses (RTTNews)
05.12.21	Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses (PR Newswire)
04.12.21	Janssen to Showcase Progress on Respiratory Syncytial Virus (RSV) Vaccine Candidate at ESWI 2021 (PR Newswire)
02.12.21	Amgen : FDA Approves Kyprolis Combination Regimen For Multiple Myeloma Treatment (RTTNews)
30.11.21	CDC Strengthens Booster Recommendation For All Adults Due To Omicron Variant Concerns (RTTNews)
29.11.21	Vaccine Makers Investigate New Covid Variant, To Adapt Shots If Needed (RTTNews)
24.11.21	Health Canada Approves Johnson & Johnson COVID-19 Vaccine - Quick Facts (RTTNews)
12.11.21	J&J Plans To Form Separate Consumer Health Company (RTTNews)
12.11.21	Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business (PR Newswire)
10.11.21	Johnson & Johnson Enters into Agreement to Provide its Single-Shot COVID-19 Vaccine for the World's Most Vulnerable People through Novel Humanitarian Buffer (PR Newswire)
09.11.21	Johnson & Johnson Endows Research!America Outstanding Achievement in Public Health Awards (PR Newswire)
22.10.21	Walgreens Offers Moderna And Johnson & Johnson COVID-19 Vaccine Booster Shots In U.S. (RTTNews)
22.10.21	CDC Panel Backs Johnson & Johnson COVID-19 Booster Shot (RTTNews)
22.10.21	U.S. CDC Advisory Committee Unanimously Recommends Johnson & Johnson COVID-19 Vaccine as a Booster for All Eligible Individuals Who Receive Authorized COVID-19 Vaccines (PR Newswire)
21.10.21	Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2021 (PR Newswire)
21.10.21	FDA Authorizes Johnson & Johnson And Moderna Booster Shots (RTTNews)
21.10.21	Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA (PR Newswire)
19.10.21	Will FDA Allow 'mix And Match' Of Covid Booster Shots? (RTTNews)
19.10.21	Johnson & Johnson Q3 Earnings Top Estimates; Lifts FY21 View Above Market (RTTNews)
19.10.21	Johnson & Johnson Q3 adjusted earnings Beat Estimates (RTTNews)
19.10.21	Johnson & Johnson Reports Q3 2021 Results (PR Newswire)
15.10.21	FDA Panel Unanimously Recommends J&J Covid Booster Shot (RTTNews)
15.10.21	Johnson & Johnson COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee (PR Newswire)
15.10.21	Johnson & Johnson Ovarian Cancer Victims Vow Fight to Stop J&J's Bankruptcy Scheme (PR Newswire)
14.10.21	Johnson & Johnson Takes Steps to Equitably Resolve All Current and Future Talc Claims (PR Newswire)
14.10.21	FDA Panel Convenes To Discuss Requirement Of Moderna Vaccine Booster Shots (RTTNews)
13.10.21	Johnson & Johnson to Host Business Review Highlighting Pharmaceuticals (PR Newswire)
12.10.21	Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations (PR Newswire)
12.10.21	Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021 (PR Newswire)
11.10.21	Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference (PR Newswire)
06.10.21	Janssen Pharmaceuticals' New Early-Stage Compound Shows Promise Against Dengue (RTTNews)
06.10.21	Janssen Announces Novel Mechanism of Action that Shows Promise Against Dengue in Data Published in Nature (PR Newswire)
05.10.21	Johnson & Johnson Submits Data To FDA To Support Booster Of Single-Shot COVID-19 Vaccine (RTTNews)
05.10.21	Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine (PR Newswire)
28.09.21	Johnson & Johnson Celebrates COVID-19 Vaccine Science Superheroes (PR Newswire)
21.09.21	J&J: Real-world Data Confirms Efficacy Of Vaccine In The U.S.; Booster Shows 94% Protection (RTTNews)
21.09.21	Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S. (PR Newswire)
16.09.21	Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results (PR Newswire)
14.09.21	Johnson & Johnson Ebola Vaccine Data Shows Strong Immune Response (RTTNews)
14.09.21	Johnson & Johnson Ebola Vaccine Regimen Demonstrated Robust and Durable Immune Response in Adults and Children in Data Published in The Lancet Infectious Diseases (PR Newswire)
02.09.21	Battle Against Johnson & Johnson "Texas Two-Step" Ploy Moves to New Jersey (PR Newswire)
01.09.21	FDA OK's Janssen Pharmaceutical's INVEGA HAFYERA To Treat Adults With Schizophrenia - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

17:51		Roche-Aktie höher: EU-Zulassung für Krebs-Kombination
17:13		Pfizer-Aktie dennoch fester: Entwicklung von Abnehmpille gestoppt
17:06		Ausblick: Johnson & Johnson gibt Ergebnis zum abgelaufenen Quartal bekannt
14:03		Stoxx Europe 50-Wert AstraZeneca-Aktie: Über diese Dividende können sich AstraZeneca-Aktionäre freuen
13:07		Beiersdorf-Analyse: Sell-Bewertung von Deutsche Bank AG für Beiersdorf-Aktie
10:02		DAX 40-Papier Fresenius Medical Care (FMC) St-Aktie: So viel Gewinn hätte ein Investment in Fresenius Medical Care (FMC) St von vor einem Jahr abgeworfen
10:02		DAX 40-Wert Merck-Aktie: So viel Verlust hätte eine Merck-Investition von vor 3 Jahren eingebracht
10:02		SMI-Papier Novartis-Aktie: Wäre eine Novartis-Investition von vor einem Jahr rentabel gewesen?

17:51

Roche-Aktie höher: EU-Zulassung für Krebs-Kombination

17:13

Pfizer-Aktie dennoch fester: Entwicklung von Abnehmpille gestoppt

17:06

Ausblick: Johnson & Johnson gibt Ergebnis zum abgelaufenen Quartal bekannt

14:03

Stoxx Europe 50-Wert AstraZeneca-Aktie: Über diese Dividende können sich AstraZeneca-Aktionäre freuen

13:07

Beiersdorf-Analyse: Sell-Bewertung von Deutsche Bank AG für Beiersdorf-Aktie

10:02

DAX 40-Papier Fresenius Medical Care (FMC) St-Aktie: So viel Gewinn hätte ein Investment in Fresenius Medical Care (FMC) St von vor einem Jahr abgeworfen

10:02

DAX 40-Wert Merck-Aktie: So viel Verlust hätte eine Merck-Investition von vor 3 Jahren eingebracht

10:02

SMI-Papier Novartis-Aktie: Wäre eine Novartis-Investition von vor einem Jahr rentabel gewesen?

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Logitech Intl	60.70	6.60 %	K V
Part Grp Hldg	1’055.50	3.38 %	K V
Roche Hldg G	251.70	3.24 %	K V
Novartis	88.74	3.08 %	K V
UBS Group	23.46	2.89 %	K V
Lonza Grp	531.80	1.57 %	K V
Swisscom	522.00	1.26 %	K V
Nestle	86.05	1.26 %	K V
CieFinRichemont	137.00	0.92 %	K V
Givaudan	3’745.00	0.83 %	K V

Johnson & Johnson Aktie VALOR 943981 / ISIN US4781601046

Nachrichten zu Johnson & Johnson

Aktien Top/Flop

Johnson & Johnson Peer Group Nachrichten

Meistgelesene Nachrichten